RxDoctor Payments Data

Alexander Shustorovich, DO

Pain Medicine · Edison, NJNPI 1306372552

Payments from drug & device makers

What this record shows

This record is dominated by grants: $15,000 of the $24,700 with a category attached, or 60.7%. Boston Scientific accounts for 68.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $15,676 and has fallen 97.9% since, to $330 in 2025. Among pain medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,700in general payments, 2019–2025

Across 88 payments — averaging $280.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$17K
  • Averitas Pharma Inc.$5K
  • Nevro Corp.$996
  • SPR Therapeutics, Inc$631
  • Saluda Medical Americas, Inc.$212
  • Medtronic$190
  • plus $457 from 7 others

What the payments were for

  • Speaking & faculty fees$4,75019%
  • Grants$15,00061%
  • Travel & lodging$1,1865%
  • Food & beverage$3,04112%
  • Education$7233%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,700 in reported general payments places this provider in the 95th percentile of 256 pain medicine providers in New Jersey.

See all pain medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$54,766
Medicare patients
231
Services billed
602

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium30$1,912
Celecoxib62$1,562
Gabapentin121$1,366
Methocarbamol61$793
Duloxetine Hcl58$638
Pregabalin50$562
Baclofen29$439
Naproxen36$295
Tizanidine Hcl22$194
Meloxicam41$171
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$169
Cyclobenzaprine Hcl12$148
Methylprednisolone14$123
Tramadol Hcl14$95

Paid to pharmacies, not to this prescriber.

Other pain medicine in Edison

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →